Korea vs Nepal: The number of people with susceptibility test result for rifampicin
Korea
9,284
in 2021
Nepal
11,863
in 2021
Korea rank
22nd
Nepal rank
19th
The number of people with susceptibility test result for rifampicin over time
- Korea
- Nepal
How they compare
Nepal currently reports 11,863 against 9,284 in Korea, a difference of 2,579.
That makes Nepal's figure about 1.3 times Korea's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Korea ahead.
Korea ranks 22nd and Nepal ranks 19th of 155 countries.
Across the 2 decades both report, Korea averaged higher in 1 and Nepal in 1.
Head to head by decade
| Decade | Korea | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13,475 | 6,955 | 6,520 | Korea |
| 2020s | 9,936 | 9,999 | 62.5 | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Korea or Nepal?
- Nepal, at 11,863 against 9,284 in Korea as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Korea and Nepal?
- 2,579, with Nepal ahead.
- How many years of comparable data are there for Korea and Nepal?
- 5 years are reported by both, from 2017 to 2021.
- How do Korea and Nepal rank globally for the number of people with susceptibility test result for rifampicin?
- Korea ranks 22nd and Nepal ranks 19th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.